A network of researchers looking to foster collaboration in several therapeutic fields.

Clinical and fundamental research, job opportunities, faculties' interests and links to gene therapy sites - joint project of Baylor College of Medicine, Texas Children's Hospital, and The Methodist Hospital in Houston, TX.

The center links basic science, clinical investigation and technology transfer endeavors in the area of gene therapy, while also serving as a resource for information and education.

The mission of the Centre is to investigate, create and implement approaches utilizing the delivery of genes as therapeutic agents in the treatment of human and animal disease.

A joint initiative of The New Children's Hospital and the Children's Medical Research Institute is undertaking gene therapy clinical trials in Australia. Research projects include cancer immunotherapy, vector development, HIV infection, targeting gene delivery to specific tissue types.

Conducts basic biomedical research into therapies for Down Syndrome, ALS, cancer, and Rec8 Syndrome. Includes map of chromosone 21, employment details and links to related resources.

The human cancer gene prevention and therapy program conducts basic research, clinical trials and vector development.

Aims to enhance the development of safe and effective gene therapy by supporting research projects, from vector development and construction to production of biologicals for human use and their application in GCP clinical trials.

The group performs basic research on viruses in order to facilitate the development of efficient gene-transfer vectors for use in gene therapy. Current research concerns the human adenoviruses and the systems required for producing recombinant-adenovirus vectors.

An interactive group of academic production and pharmacology/toxicology laboratories whose primary goal is to provide eligible investigators with clinical grade vectors for phase I/II gene therapy clinical trials and to provide support for relevant pharmacology/toxicology studies leading up to clinical gene transfer protocols.